Glycation in diabetes: is it the same in all patients?
Authors:
Jan Škrha jr.
Authors place of work:
3. interní klinika – klinika endokrinologie a metabolismu 1. LF UK a VFN v Praze
Published in the journal:
Čas. Lék. čes. 2024; 163: 185-188
Category:
Review Articles
Summary
Glycation plays a crucial role in the development of chronic vascular complications in diabetes. The total individual glycation is a result of interaction between proglycation and deglycation mechanisms and can be expressed by hemoglobin glycation index (HGI). There is increasing evidence that patients with higher glycation (and higher HGI) suffer from more frequent diabetic complications. In practice, it would therefore be advantageous to identify and treat such patients to stricter glycemic goals.
Keywords:
hemoglobin glycation index, glucose management indicator, glycated hemoglobin, continuous glucose monitoring, diabetes mellitus
Zdroje
1. Shah VN, Vigers T, Pyle L et al. Discordance between glucose management indicator and glycated hemoglobin in people without diabetes. Diabetes Technol Ther 2023; 25: 324–328.
2. Dunmore SJ, Al-Derawi AS, Nayak AU et al. Evidence that differences in fructosamine-3-kinase activity may be associated with the glycation gap in human diabetes. Diabetes 2018; 67: 131–136.
3. Xu Y, Bergenstal RM, Dunn TC et al. Interindividual variability in average glucose-glycated haemoglobin relationship in type 1 diabetes and implications for clinical practice. Diabetes Obes Metab 2022; 24: 1779–1787.
4. Perlman JE, Gooley TA, McNulty B et al. HbA1c and glucose management indicator discordance: a real-world analysis. Diabetes Technol Ther 2021; 23: 253–258.
5. Ribeiro RT, Macedo MP, Raposo JF. HbA1c, fructosamine, and glycated albumin in the detection of dysglycaemic conditions. Curr Diabetes Rev 2016; 12: 14–19.
6. Škrha J jr., Šoupal J, Prázný M. Glykace proteinů oční čočky u diabetiků a její neinvazivní měření – první zkušenosti v České republice. Vnitř Lék 2015; 61: 346–350.
7. Blanc-Bisson C, Velayoudom-Cephise FL, Cougnard-Gregoire A et al. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study. Cardiovasc Diabetol 2018; 17: 82.
8. Šoupal J, Petruželková L, Grunberger G et al. Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR Study. Diabetes Care 2020; 43: 37–43.
9. Heinemann L, Freckmann G, Ehrmann D et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet 2018; 391: 1367–1377.
10. Beck RW, Connor CG, Mullen DM et al. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care 2017; 40(8): 994-999.
11. Piona C, Marigliano M, Mozzillo E et al. Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes. Pediatr Diabetes 2022; 23: 84–89.
12. Shah VN, Vigers T, Pyle L et al. Discordance between glucose management indicator and glycated hemoglobin in people without diabetes. Diabetes Technol Ther 2023; 25: 324–328.
13. Nayak AU, Singh BM, Dunmore SJ. Potential clinical error arising from use of HbA1c in diabetes: effects of the glycation gap. Endocr Rev 2019; 40: 988–999.
14. Škrha J Jr., Muravská A, Flekač M et al. Fructosamine 3-kinase and glyoxalase i polymorphisms and their association with soluble RAGE and adhesion molecules in diabetes. Physiol Res 2014; 63: S283–S291.
15. Cohen RM, Snieder H, Lindsell CJ et al. Evidence for independent heritability of the glycation gap, (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care 2006; 29: 1739–1743.
16. Rodriguez-Segade S, Rodriguez J, Lopez JMG et al. Estimation of the glycation gap in diabetic patients with stable glycemic control. Diabetes Care 2012; 35: 2447–2450.
17. Sakane N, Hirota Y, Yamamoto A et al. Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study. J Diab Invest 2023; 14: 582–590.
18. McCarter RJ, Gomez R, Hempe JM et al. Biological variation in HbA(1c) predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 2004; 27: 1259–1264.
19. van Steen SC, Schrieks IC, Hoekstra JB et al. The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial. Eur J Prev Cardiol 2017; 24: 858–866.
20. Cheng PC, Hsu SR, Cheng YC et al. Relationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus: a cross-sectional study. PeerJ 2017; 5: e3875.
21. Hirakawa Y, Arima H, Zoungas S et al. Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: The ADVANCE Trial. Diabetes Care 2014; 37: 2359–2365.
22. Hempe JM, Yang SP, Liu SQ, Hsia DS. Standardizing the haemoglobin glycation index. Endocrinol Diabetes Metab 2021; 4: e00299.
23. Škrha J, Šoupal J, Škrha J Jr. et al. Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord 2016; 17: 103–110.
24. Hempe JM, Liu S, Myers L et al. The Hemoglobin Glycation Index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD Trial. Diabetes Care 2015; 38: 1067–1074.
25. Zhou M, Zhang Y, Shi L et al. Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – a review. Pharmacol Res 2024; 206: 107282.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Culturally sensitive health care – cultural specifics of Roma patients
- Glucose variability and diabetic microvascular complications
- Diabetic foot attack
- Automated insulin delivery systems – settings in specific situations